latest news releases from the newsroom
KDS USA Unveils Affordable Pair of 17-Inch 'Pure Flat' Desktop Displays
GARDEN GROVE, Calif., Sept. 3, 2003 (PRIMEZONE) -- KDS USA, a leading provider of monitors and computer peripherals, today introduced its new pair of Xtreme Flat 'pure flat' desktop displays. The 17-inch XF-7i (available in cool grey) and XF-7bk (available in black) CRT monitors afford consumers sharp and crisp images for high-end graphics, gaming, business and everyday computing applications.
Odfjell -- Presentation
OSLO, Norway, Sept. 3, 2003 (PRIMEZONE) -- A copy of the presentation of Odfjell (Other OTC:ODJLY) held by Bjoern Sjaastad at yesterday's Holberg Forvaltning seminar is enclosed at the following link: http://reports.huginonline.com/916132/122650.pdf
Crucell and Kimron Veterinary Institute Announce Anticipated Approval of West Nile Veterinary Vaccine Early 2004
LEIDEN, The Netherlands, Sept. 03, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and Israeli Kimron Veterinary Institute announced today that they anticipate approval of a veterinary West Nile vaccine in early 2004. Kimron had previously expected to register the PER.C6(TM)-based West Nile veterinary vaccine at the end of 2004. Based on encouraging results from the initial pre-clinical studies, Kimron now will conduct a field trial during the 2003 mosquito season to ensure that the licensed vaccine is available before the start of the 2004 mosquito season. Kimron signed a license agreement with Crucell in June 2003 to use Crucell's PER.C6(TM) cell line technology to develop a West Nile veterinary vaccine. The PER.C6(TM)-based West Nile veterinary vaccine is a whole-killed vaccine, which means that the virus is inactivated, yet able to elicit a strong and effective immune response. The new vaccine is expected to have improved purity at competitive costs.